Integer HoldingsITGR
About: Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.
Employees: 11,000
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
5,107% more call options, than puts
Call options by funds: $81.1M | Put options by funds: $1.56M
200% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 3 (+2) [Q1 2025]
97% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 35
8% more funds holding
Funds holding: 327 [Q4 2024] → 354 (+27) [Q1 2025]
0.6% more ownership
Funds ownership: 117.69% [Q4 2024] → 118.29% (+0.6%) [Q1 2025]
10% less capital invested
Capital invested by funds: $5.23B [Q4 2024] → $4.69B (-$538M) [Q1 2025]
23% less repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 128
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Citigroup Joanne Wuensch | 18%upside $140 | Buy Upgraded | 22 May 2025 |
Truist Securities Richard Newitter | 27%upside $150 | Buy Maintained | 28 Apr 2025 |
Raymond James Andrew Cooper | 27%upside $150 | Outperform Maintained | 25 Apr 2025 |
Benchmark Robert Wasserman | 18%upside $140 | Buy Maintained | 25 Apr 2025 |
Keybanc Tim Rezvan | 23%upside $145 | Overweight Maintained | 21 Apr 2025 |
Financial journalist opinion
Based on 7 articles about ITGR published over the past 30 days









